Webb10 mars 2024 · Company. Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is engaged in developing a range of immune-modulatory agents to target certain cancers, … Webb1 maj 2024 · OCEANSIDE, CA--(Marketwired - May 01, 2024) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the Board of Directors of its majority owned subsidiary, Emvolio, Inc. (Emvolio) has appointed Thomas E. Ichim, PhD, as Chief Executive Officer of Emvolio.. Dr. Ichim is a seasoned biotechnology entrepreneur …
THERAPEUTIC SOLUTIONS INTL INC(TSOI)其他公告 - Moomoo
Webb12 apr. 2024 · Therapeutic Solutions International, Inc. engages in the manufacture of surgical and medical devices. It develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal... Webb10 apr. 2024 · OCEANSIDE, CA--(Marketwired - April 10, 2024) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a new patent and exclusive licensing agreement with majority owned subsidiary Emvolio, Inc.. The patent describes methods of cancer treatment through the administration of proteins or … picture of a crying face
TSOI: Therapeutic Solutions International Inc - CNBC
WebbTherapeutic Solutions International Develops Novel Stem Cell Based Therapy to Reduce Lung Scarring: Potential Solution to Post COVID-19 Lung Deterioration PR Newswire - PRF - Fri May 21, 8:00AM CDT , /PRNewswire/ -- Therapeutic Solutions International, Inc., … Webb20 apr. 2024 · Thursday, April 13, 2024 1:13:31 PM. Post # of 57459. sometimes, even though a flattened out technical chart may indicate a potential bottom, it doesn't guarantee a rebound in stock price. Additionally, the conversion of patents into revenue is not always a straightforward process and may take time and resources to accomplish. WebbOCEANSIDE, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today new data and the filing of a patent application covering the ability of NanoStilbene™ [1] and its active ingredient, pterostilbene, at accelerating recovery of blood cells after treatment with … top down prototypen